(Reuters) – The U.S. Food and Drug Administration said on Wednesday its outside advisers will meet on Sept. 17 to discuss additional doses of COVID-19 vaccines and specifically Pfizer Inc and partner BioNTech’s application for the use of a booster vaccine dose.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
